ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed
Fast Publication within 48 hours || Low Article Processing Charges || Peer Reviewed and Referred Journal || Free Certificate
Regulatory pharmacy strategies for reducing drug development costs in underserved population
Faculty of Pharmacy, University of Lagos, Nigeria.
Research Article
International Journal of Science and Research Archive, 2022, 06(02), 315–319.
Article DOI: 10.30574/ijsra.2022.6.2.0167
Publication history:
Received on 04 July 2022; revised on 20 August 2022; accepted on 24 August 2022
Abstract:
The rising costs of drug development present a critical challenge, particularly for underserved populations, who often struggle to access essential medicines. This paper examines several regulatory strategies to reduce these costs, such as adaptive regulatory frameworks, incentives for orphan drug development, leveraging real-world evidence (RWE), public-private partnerships (PPPs), and promoting generic drug development. These strategies offer pathways to balance innovation with affordability, thereby addressing health disparities.
Keywords:
Regulatory; Drug Development Costs; Pharmacy Strategies; Underserved Populations
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
